Mechanisms of botulinum toxin type A action on pain

Ivica Matak, K. Bölcskei, Lidija Bach-Rojecky, Z. Helyes

Research output: Contribution to journalReview article

Abstract

Already a well-established treatment for different autonomic and movement disorders, the use of botulinum toxin type A (BoNT/A) in pain conditions is now continuously expanding. Currently, the only approved use of BoNT/A in relation to pain is the treatment of chronic migraines. However, controlled clinical studies show promising results in neuropathic and other chronic pain disorders. In comparison with other conventional and non-conventional analgesic drugs, the greatest advantages of BoNT/A use are its sustained effect after a single application and its safety. Its efficacy in certain therapy-resistant pain conditions is of special importance. Novel results in recent years has led to a better understanding of its actions, although further experimental and clinical research is warranted. Here, we summarize the effects contributing to these advantageous properties of BoNT/A in pain therapy, specific actions along the nociceptive pathway, consequences of its central activities, the molecular mechanisms of actions in neurons, and general pharmacokinetic parameters.

Original languageEnglish
Article number459
JournalToxins
Volume11
Issue number8
DOIs
Publication statusPublished - Aug 1 2019

Fingerprint

Type A Botulinum Toxins
Pain
Somatoform Disorders
Pharmacokinetics
Movement Disorders
Therapeutics
Migraine Disorders
Chronic Pain
Neurons
Analgesics
Safety
Research

Keywords

  • Botulinum toxin type A
  • Mechanism of action
  • Migraine
  • Neuropathic pain
  • Pain therapy

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Mechanisms of botulinum toxin type A action on pain. / Matak, Ivica; Bölcskei, K.; Bach-Rojecky, Lidija; Helyes, Z.

In: Toxins, Vol. 11, No. 8, 459, 01.08.2019.

Research output: Contribution to journalReview article

Matak, Ivica ; Bölcskei, K. ; Bach-Rojecky, Lidija ; Helyes, Z. / Mechanisms of botulinum toxin type A action on pain. In: Toxins. 2019 ; Vol. 11, No. 8.
@article{c9c42a7b11f9442b9e78f32abe8fcd1c,
title = "Mechanisms of botulinum toxin type A action on pain",
abstract = "Already a well-established treatment for different autonomic and movement disorders, the use of botulinum toxin type A (BoNT/A) in pain conditions is now continuously expanding. Currently, the only approved use of BoNT/A in relation to pain is the treatment of chronic migraines. However, controlled clinical studies show promising results in neuropathic and other chronic pain disorders. In comparison with other conventional and non-conventional analgesic drugs, the greatest advantages of BoNT/A use are its sustained effect after a single application and its safety. Its efficacy in certain therapy-resistant pain conditions is of special importance. Novel results in recent years has led to a better understanding of its actions, although further experimental and clinical research is warranted. Here, we summarize the effects contributing to these advantageous properties of BoNT/A in pain therapy, specific actions along the nociceptive pathway, consequences of its central activities, the molecular mechanisms of actions in neurons, and general pharmacokinetic parameters.",
keywords = "Botulinum toxin type A, Mechanism of action, Migraine, Neuropathic pain, Pain therapy",
author = "Ivica Matak and K. B{\"o}lcskei and Lidija Bach-Rojecky and Z. Helyes",
year = "2019",
month = "8",
day = "1",
doi = "10.3390/toxins11080459",
language = "English",
volume = "11",
journal = "Toxins",
issn = "2072-6651",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "8",

}

TY - JOUR

T1 - Mechanisms of botulinum toxin type A action on pain

AU - Matak, Ivica

AU - Bölcskei, K.

AU - Bach-Rojecky, Lidija

AU - Helyes, Z.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Already a well-established treatment for different autonomic and movement disorders, the use of botulinum toxin type A (BoNT/A) in pain conditions is now continuously expanding. Currently, the only approved use of BoNT/A in relation to pain is the treatment of chronic migraines. However, controlled clinical studies show promising results in neuropathic and other chronic pain disorders. In comparison with other conventional and non-conventional analgesic drugs, the greatest advantages of BoNT/A use are its sustained effect after a single application and its safety. Its efficacy in certain therapy-resistant pain conditions is of special importance. Novel results in recent years has led to a better understanding of its actions, although further experimental and clinical research is warranted. Here, we summarize the effects contributing to these advantageous properties of BoNT/A in pain therapy, specific actions along the nociceptive pathway, consequences of its central activities, the molecular mechanisms of actions in neurons, and general pharmacokinetic parameters.

AB - Already a well-established treatment for different autonomic and movement disorders, the use of botulinum toxin type A (BoNT/A) in pain conditions is now continuously expanding. Currently, the only approved use of BoNT/A in relation to pain is the treatment of chronic migraines. However, controlled clinical studies show promising results in neuropathic and other chronic pain disorders. In comparison with other conventional and non-conventional analgesic drugs, the greatest advantages of BoNT/A use are its sustained effect after a single application and its safety. Its efficacy in certain therapy-resistant pain conditions is of special importance. Novel results in recent years has led to a better understanding of its actions, although further experimental and clinical research is warranted. Here, we summarize the effects contributing to these advantageous properties of BoNT/A in pain therapy, specific actions along the nociceptive pathway, consequences of its central activities, the molecular mechanisms of actions in neurons, and general pharmacokinetic parameters.

KW - Botulinum toxin type A

KW - Mechanism of action

KW - Migraine

KW - Neuropathic pain

KW - Pain therapy

UR - http://www.scopus.com/inward/record.url?scp=85071147498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071147498&partnerID=8YFLogxK

U2 - 10.3390/toxins11080459

DO - 10.3390/toxins11080459

M3 - Review article

VL - 11

JO - Toxins

JF - Toxins

SN - 2072-6651

IS - 8

M1 - 459

ER -